Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Chronic Disease Management Market, by Type
1.4.2 Europe Chronic Disease Management Market, by End User
1.4.3 Europe Chronic Disease Management Market, by Disease Type
1.4.4 Europe Chronic Disease Management Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Sep – 2022, May) Leading Players
Chapter 4. Europe Chronic Disease Management Market by Type
4.1 Europe Solutions Market by Country
4.2 Europe Services Market by Country
Chapter 5. Europe Chronic Disease Management Market by End User
5.1 Europe Healthcare Providers Market by Country
5.2 Europe Healthcare Payers Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Chronic Disease Management Market by Disease Type
6.1 Europe Diabetes Market by Country
6.2 Europe Cardiovascular diseases Market by Country
6.3 Europe Asthma Market by Country
6.4 Europe Chronic obstructive pulmonary disorders Market by Country
6.5 Europe Cancer Market by Country
6.6 Europe Others Market by Country
Chapter 7. Europe Chronic Disease Management Market by Country
7.1 Germany Chronic Disease Management Market
7.1.1 Germany Chronic Disease Management Market by Type
7.1.2 Germany Chronic Disease Management Market by End User
7.1.3 Germany Chronic Disease Management Market by Disease Type
7.2 UK Chronic Disease Management Market
7.2.1 UK Chronic Disease Management Market by Type
7.2.2 UK Chronic Disease Management Market by End User
7.2.3 UK Chronic Disease Management Market by Disease Type
7.3 France Chronic Disease Management Market
7.3.1 France Chronic Disease Management Market by Type
7.3.2 France Chronic Disease Management Market by End User
7.3.3 France Chronic Disease Management Market by Disease Type
7.4 Russia Chronic Disease Management Market
7.4.1 Russia Chronic Disease Management Market by Type
7.4.2 Russia Chronic Disease Management Market by End User
7.4.3 Russia Chronic Disease Management Market by Disease Type
7.5 Spain Chronic Disease Management Market
7.5.1 Spain Chronic Disease Management Market by Type
7.5.2 Spain Chronic Disease Management Market by End User
7.5.3 Spain Chronic Disease Management Market by Disease Type
7.6 Italy Chronic Disease Management Market
7.6.1 Italy Chronic Disease Management Market by Type
7.6.2 Italy Chronic Disease Management Market by End User
7.6.3 Italy Chronic Disease Management Market by Disease Type
7.7 Rest of Europe Chronic Disease Management Market
7.7.1 Rest of Europe Chronic Disease Management Market by Type
7.7.2 Rest of Europe Chronic Disease Management Market by End User
7.7.3 Rest of Europe Chronic Disease Management Market by Disease Type
Chapter 8. Company Profiles
8.1 Infosys Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 ExlService Holdings, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.3 Health Catalyst, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 AllScripts Healthcare Solutions, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional & Segmental Analysis
8.4.4 Research & Development Expenses
8.5 Koninklijke Philips N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.5.5.4 Approvals and Trials:
8.6 Cognizant Technology Solutions Corporation
8.6.1 Company overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.5 SWOT Analysis
8.7 Casenet, LLC (Zyter, Inc.)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Cedar Gate Technologies
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
8.9 Clinical Excellence, Inc.
8.9.1 Company Overview
8.10. Altruista Health, Inc. (HealthEdge Software, Inc.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:
Unique Offerings 
